Blog
Why do I pay coinsurance on a drug price my plan gets a rebate on?
List price, net price and rebates explained, why most coinsurance is figured before the rebate, what supporters and critics say, and what you can ask your plan.
If your plan charges 30% coinsurance on a brand-name drug, you might reasonably assume that 30% of what the plan really pays is yours. Often it is not. The price your percentage is applied to is usually a price from before a manufacturer's rebate, and the rebate goes to the plan, not to you. That can leave you covering a larger share of what the drug actually costs the system than the printed 30% suggests.
This is an explainer about how that mechanism works. It uses invented numbers, lays out what each side of the policy argument says and ends with questions you can ask your own plan. It does not say what any plan should do.
Three prices that get confused
The word "price" covers at least three different amounts in prescription drug coverage.
- List price. The price the manufacturer sets for the drug before discounts. Also called the wholesale acquisition cost or, loosely, the sticker price. It is published and is the starting point for many contracts.
- The price at the counter. What the pharmacy is allowed to charge for a claim under its contract with your plan or the plan's pharmacy benefit manager. It is usually close to the list price for a brand drug, and it is the number your cost sharing is figured from.
- Net price. What the drug costs after discounts and rebates. This is a figure only the manufacturer, the plan and the benefit manager can compute, because rebate terms are generally confidential.
The gap between list and net is why a drug can be expensive to a patient and cheaper to a plan at the same time.
What a rebate is
A drug rebate is a payment from a drug manufacturer to a benefit manager or plan after a drug is dispensed. Manufacturers pay rebates for several reasons. A plan may put the manufacturer's drug on its drug list, the formulary tier structure, at a lower tier, or may require patients to try it before a competitor. In return the manufacturer agrees to pay back a percentage of the list price on each fill.
Three features matter for you:
- Rebates are paid after the claim. They arrive in periodic payments, usually quarterly, based on the claims a benefit manager processed.
- Rebates are paid to the plan or benefit manager. The plan sponsor, which is often your employer or an insurer, receives some or all of the money, according to its contract. Benefit managers may keep a portion or charge fees.
- Rebates are mostly secret. Contract terms are generally treated as confidential. A patient cannot look up the rebate on a given drug.
For generic drug products there is usually little or no rebate. Generics compete mainly on a low price at the counter. Rebates are most common for brand products, where manufacturers compete for a place on the drug list.
Why coinsurance is usually calculated before the rebate
At the counter, your plan needs to decide your share in a fraction of a second. It uses the price in the claim. The rebate is not part of the claim, because it has not been negotiated for that specific fill and has not arrived. It is an adjustment between the plan and the manufacturer later.
Most plans therefore calculate coinsurance on the counter price. The effect is simple: a percentage of a larger number is a larger payment. The rebate's benefit goes to the plan sponsor, which may use it to offset premiums or plan costs, but your own payment does not shrink.
The same applies to the deductible. Money you pay toward the deductible for a drug is typically counted at the counter price. See what is a deductible and how does it work in health insurance? for how the deductible works.
A worked example
This is a hypothetical with round numbers, not a real drug or contract. To keep the arithmetic readable, it ignores the pharmacy's margin and the benefit manager's fees, and assumes the plan receives the whole rebate.
- List and counter price: $400 per fill.
- Rebate from the manufacturer: 40%, or $160.
- Net price: $400 − $160 = $240.
- Your coinsurance: 30%.
How it works under a typical plan.
- You pay 30% × $400 = $120 at the counter.
- The plan pays $400 − $120 = $280 at the counter.
- Later, the plan receives $160 in rebates, so its net outlay is $280 − $160 = $120.
- Check: you $120 + plan $120 = $240, the net price.
Notice that you paid $120 and the plan netted $120. Your share of the net price is $120 ÷ $240 = 50%, not 30%. The plan's printed coinsurance rate is 30%, but your effective share of what the drug costs after the rebate is 50% in this example.
What would change if coinsurance used the net price.
- 30% × $240 = $72 for you.
- The plan pays $400 − $72 = $328 at the counter and receives $160 later, for a net of $168.
- Check: you $72 + plan $168 = $240.
You would pay $48 less per fill, and the plan would pay $48 more. Over 12 monthly fills, that is $576 less for you and $576 more for the plan, which in turn might be spread across all members through premiums. Whether that trade is worthwhile is exactly what people disagree about.
How a copay changes the picture
A flat copay avoids the percentage problem. Say the same drug sits on a tier with a $60 copay.
- You pay $60.
- The plan pays $340 at the counter and nets $340 − $160 = $180.
- Check: you $60 + plan $180 = $240.
Your share of the net price is 25%. A copay does not follow the list price up or down, so it is predictable, but plans set copays based on their own view of tier and cost. See premium, deductible, copay and coinsurance explained simply for the difference between the two.
What happens in the deductible phase
If you have not yet met your deductible, you pay the full counter price. In the example, that is $400 for the first fill, and the plan pays nothing at the counter. Later the plan still receives the rebate on the claim, in this example $160. So in the deductible phase the money that reaches the plan from the rebate is larger than the plan's own payment. For patients in high-deductible plans, this is the situation that produces the loudest objections: they pay the pre-rebate price while the plan collects a rebate on the same fill.
Whether a rebate is counted against what the patient is considered to have paid depends on the plan and the law that applies to it. Ask the plan how spending is counted toward the deductible and the out-of-pocket maximum. Some manufacturer coupons do not count, a topic covered under copay accumulator.
The argument that rebates lower costs
Supporters of the current system, including many benefit managers and plan sponsors, make these points.
- Rebates reduce the plan's total spending, which keeps premiums lower for every member, including those who take few drugs.
- Moving rebate money to the point of sale shifts cost. A patient who uses an expensive drug would pay less at the counter. The plan would pay more, and premiums for all members might rise to cover it. Supporters say people who rarely fill expensive drugs would then subsidize those who do.
- Rebates are a tool for negotiation. The ability to move a drug to a preferred position, or exclude it, gives plans leverage over manufacturers' prices.
- Not every plan sponsor wants a counter-price change. Some employers prefer to keep the rebate to reduce plan costs overall.
The argument that rebates raise patient costs
Critics, including many patient advocates, some employers and some policymakers, make these points.
- Patients who pay coinsurance or are in a deductible bear costs based on a price that no one nets. The sicker the patient, the more they pay.
- Rebates may create an incentive for higher list prices. A rebate calculated as a percentage of the list price is larger when the list price is larger. Critics say that can favor a high-list, high-rebate drug over a lower-priced alternative. Benefit managers say manufacturers set list prices, and manufacturers have said that rebate demands push them to set higher prices. These statements conflict, and they are attributed to the parties making them.
- Opacity. Patients and, sometimes, plan sponsors cannot see the rebate terms, so they cannot judge whether the system is working.
- Patients with no rebate benefit. The uninsured, and people who pay a pre-deductible price, do not share in the rebate even though it reduces the drug's net price.
Each of these points has a counterpoint from the other side, and which arguments carry more weight depends on the drug, the plan design and the amounts involved. A neutral reading is that both a lower counter price and a lower premium can be real goals, and that policy choices decide who bears the cost. The proposals that have been put forward are covered in What PBM reform proposals would change for patients and what critics say.
What a patient can ask for
You cannot negotiate a rebate, but some questions are fair to ask.
- "Is my cost on this drug a copay or coinsurance, and what price is the coinsurance based on?" The plan's summary of benefits or member services can answer.
- "Is there a lower tier or an alternative drug that treats my condition?" The prescriber decides what is clinically suitable. The plan can tell you the tiers.
- "Does my plan have any program that applies rebates at the point of sale or shares rebate savings with members?" A few plans do; most do not.
- "Do manufacturer coupons count toward my deductible and out-of-pocket maximum?"
- "What does the pharmacy charge in cash, and does that purchase count toward my deductible?" For some generics the cash price is lower than the insured price. Cash purchases may not be credited to the plan's deductible.
- "If I have employer coverage, how does our benefit manager handle rebates?" The employer's benefits staff may be able to ask the plan administrator.
- "Where can I complain?" For fully insured plans, the state insurance department takes complaints. For other plans, the plan administrator and the Department of Labor's benefits assistance offices provide guidance.
For Medicare drug plans, a State Health Insurance Assistance Program counselor can explain how your plan's costs work and how to compare options. what pharmacy benefit managers do and why they matter covers who benefit managers are and what they do.
Putting it together
The mechanism is not a mistake in one pharmacy's computer. It is how most commercial prescription contracts are built, and it follows from three facts: coinsurance needs a price at the moment of sale, rebates are paid later, and the rebate goes to the party that negotiated it. Whether to change that is a policy question with real trade-offs. In the meantime, what matters to a patient is the price that applies at the counter, so ask about it before you fill, and ask about alternatives before you begin a drug.
Key takeaways
- Your coinsurance is usually calculated on the price at the counter, before the manufacturer's rebate, and the rebate is paid later to the plan or benefit manager.
- In the worked example, 30% coinsurance on a $400 price meant $120, which was 50% of the $240 net price after a $160 rebate.
- A flat copay does not follow the price, so it can be easier to predict, but the plan sets it.
- Supporters say rebates lower premiums for everyone, and critics say they leave patients paying on a price nobody nets and may encourage high list prices.
- Ask your plan what price your coinsurance is based on, whether a lower tier exists, and how coupons and cash purchases count.